School of Biological Sciences, Flinders University, Adelaide, SA, Australia.
J Fish Dis. 2013 Nov;36(11):939-47. doi: 10.1111/jfd.12089. Epub 2013 Mar 11.
We investigated the efficacy of praziquantel (PZQ) and fenbendazole (FBZ), each administered by bath and orally, against the monogenean Lepidotrema bidyana Murray, a gill parasite of the freshwater fish silver perch, Bidyanus bidyanus (Mitchell). PZQ and FBZ were each administered by bath at 10 mg L⁻¹ for 48 h and on surface-coated feed pellets at 75 mg kg⁻¹ per body weight (BW) per day for 6 days. Bath treatments of PZQ and FBZ had an efficacy of 99% and 91%, respectively, against adult L. bidyana. Oral treatments of PZQ and FBZ had an efficacy of 79% and 95%, respectively, against adult L. bidyana. Fish rejected feed pellets surface-coated with PZQ, suggesting that palatability of surface-coated PZQ-medicated feed is poor, which undermined efficacy. In all trials, some juvenile parasites were present on fish after treatment during efficacy assessment, indicating that efficacy may be lower against juvenile parasites or that recruitment occurred post-treatment, demonstrating that repeat treatments are necessary to effectively control L. bidyana in aquaculture.
我们研究了吡喹酮(PZQ)和芬苯达唑(FBZ)通过浸浴和口服给药对淡水鱼类银鲈鳃上寄生单殖吸虫 Lepidotrema bidyana Murray 的疗效。PZQ 和 FBZ 分别以 10 mg/L 浸浴 48 小时和以 75 mg/kg 体重/天的表面涂层饲料丸口服给药 6 天。PZQ 和 FBZ 的浸浴处理对成年 L. bidyana 的疗效分别为 99%和 91%。PZQ 和 FBZ 的口服处理对成年 L. bidyana 的疗效分别为 79%和 95%。鱼拒绝摄食表面涂层有 PZQ 的饲料丸,表明表面涂层 PZQ 给药饲料的适口性差,这降低了疗效。在所有试验中,在疗效评估期间,治疗后鱼身上仍存在一些幼体寄生虫,这表明幼体寄生虫的疗效可能较低,或者在治疗后出现了新的寄生虫感染,这表明需要重复治疗才能有效地控制水产养殖中的 L. bidyana。